Key facts
- This page summarizes Alexandra Balcom's Form 4 filing for Nuvalent, Inc. (NUVL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jan 2024, 16:49.
Alexandra Balcom - 05 Jan 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- NUVL
- Reported as of
- 05 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2024, 16:49:09 UTC
- Prior SEC filing
- 20 Dec 2023
- Next SEC filing
- 02 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Deborah Ann Miller, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexandra Balcom filed Form 4 for Nuvalent, Inc. (NUVL) on 09 Jan 2024.
Change
- Previous filing in this sequence was filed on 20 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUVL
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +33,300
- Change %
- Price
- $0.000000
- Shares after
- 33,300
- Date
- 05 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUVL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +47,500
- Change %
- Price
- $0.000000
- Shares after
- 47,500
- Date
- 05 Jan 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 47,500
- Exercise price
- $72.35
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following January 5, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Footnote F2
The shares underlying this option vest over the next four years in equal monthly installments following January 5, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.